HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a prospective study.

AbstractOBJECTIVE:
In this prospective study, we investigated whether the development of interferon (IFN)-alpha-related autoimmune thyroiditis (IFN-AT) was correlated with the sequential changes of cytokine pattern induced by IFNalpha in the peripheral lymphocytes.
PATIENTS AND METHODS:
We enrolled 18 hepatitis C virus (HCV)-positive patients who developed IFN-AT, eight patients with euthyroidism [IFN-AT(Eu)] and 10 with thyroid dysfunction [IFN-AT(Dy)]. Twenty HCV-positive patients without IFN-AT acted as control group (Co-HCV+). Intracellular expression of IFNgamma and IL-4 was evaluated by multicolor flow-cytometry analysis in peripheral lymphocytes in vitro stimulated by phorbol-12-myristate-13-acetate (PMA) (25 ng/ml) and ionomycin (1 mug/ml) in presence of monensin (5 microm).
RESULTS:
At the appearance of thyroid disease, both IFN-AT(Eu) and IFN-AT(Dy) patients showed a significant increase of IFNgamma expression in CD3+CD56+ and CD3-CD56+ cells but not in CD4+ and CD8+ cells. At this time point, IFN-AT(Eu) but not IFN-AT(Dy) patients also showed an increase of IL-4 expression in CD3+CD56+ cells and CD4+ cells. Six months later, IFN-AT(Eu) patients maintained high expression of IL-4 in CD4+ and CD3+CD56+ cells without any further increase in IFNgamma expression. By contrast, IFN-AT(Dy) patients showed an increase of IFNgamma expression in CD4+ and CD8+ cells, with a concomitant decrease of IL-4 expression in CD4+ cells.
CONCLUSIONS:
Type 2 immune response is activated early and specifically in patients with IFN-AT who remain euthyroid throughout the follow-up. Predominant in patients developing thyroid dysfunction, by contrast, is the type 1 immune response that seems to occur earlier in innate than acquired immune system.
AuthorsG Mazziotti, F Sorvillo, M Piscopo, F Morisco, M Cioffi, G Stornaiuolo, G B Gaeta, A M Molinari, J H Lazarus, G Amato, C Carella
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 90 Issue 7 Pg. 4138-44 (Jul 2005) ISSN: 0021-972X [Print] United States
PMID15855253 (Publication Type: Journal Article)
Chemical References
  • Interferon-alpha
  • Interleukin-4
  • Interferon-gamma
Topics
  • Adult
  • Female
  • Humans
  • Immunity, Innate
  • Interferon-alpha (adverse effects)
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (biosynthesis)
  • Male
  • Middle Aged
  • Th1 Cells (immunology)
  • Th2 Cells (immunology)
  • Thyroiditis, Autoimmune (etiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: